PER 2.50% 8.2¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-118

  1. 98 Posts.
    lightbulb Created with Sketch. 16
    To clarify I wrote to Mr Gennadi as he is listed as the investor relations contact on the annexures. Dont have a direct contact into the company unfortunately although some LTHs here may have better luck if they do in getting a more complete response from Diamond. In other biotech companies i trade ive seen responses as quick as within 5 minutes by email from the CEO which would have been nice on this occasion. Either way its a good opportunity if the market has mispriced the info
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.2¢ 8.7¢ 7.9¢ $122.1K 1.460M

Buyers (Bids)

No. Vol. Price($)
1 50000 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 6250 1
View Market Depth
Last trade - 15.59pm 10/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.